BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18474486)

  • 1. Primary cutaneous anaplastic large cell lymphoma successfully treated with low-dose oral methotrexate.
    Fujita H; Nagatani T; Miyazawa M; Wada H; Koiwa K; Komatsu H; Ikezawa Z
    Eur J Dermatol; 2008; 18(3):360-1. PubMed ID: 18474486
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary cutaneous CD30+ anaplastic large-cell lymphoma with generalized skin involvement and involvement of one peripheral lymph node, successfully treated with low-dose oral etoposide.
    Yamane N; Kato N; Nishimura M; Ito M; Yanagi T; Osawa R
    Clin Exp Dermatol; 2009 Jul; 34(5):e56-9. PubMed ID: 19438576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous CD30 positive anaplastic large cell lymphoma in an adolescent.
    Vaid R; Cohen B
    Pediatr Dermatol; 2009; 26(6):721-4. PubMed ID: 20199449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application.
    Lee JH; Cheng AL; Lin CW; Kuo SH
    Br J Dermatol; 2009 Apr; 160(4):887-9. PubMed ID: 19222454
    [No Abstract]   [Full Text] [Related]  

  • 5. Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders.
    Kadin ME
    Oncology (Williston Park); 2009 Nov; 23(13):1158-64. PubMed ID: 20043465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of CD30+ cutaneous anaplastic large-cell lymphoma with denileukin diftitox.
    Dao H; Barr PM; Honda K
    J Am Acad Dermatol; 2011 Jun; 64(6):e123-5. PubMed ID: 21571160
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary cutaneous CD30-positive anaplastic large cell lymphoma in an 80-year-old man: a case report from Nepal.
    Parajuli S; Gurung D; Paudel U; Pokhrel DB; Kempf W
    Int J Dermatol; 2014 Dec; 53(12):1498-500. PubMed ID: 24738699
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective IgM deficiency in CD30+ cutaneous lymphoproliferative disorder.
    Saini S; Dettore AJ; Bhambhani KJ; Buck S; Poulik J; Savaşan S
    J Pediatr Hematol Oncol; 2011 May; 33(4):e156-9. PubMed ID: 21516014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous CD30+ lymphoproliferative disorder successfully treated by etretinate.
    Nakamura S; Hashimoto Y; Nishi K; Mizumoto T; Takahashi H; Iizuka H
    Eur J Dermatol; 2012; 22(5):709-10. PubMed ID: 22929532
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary cutaneous CD30+ anaplastic large cell lymphoma responds to imiquimod cream.
    Ehst BD; Dréno B; Vonderheid EC
    Eur J Dermatol; 2008; 18(4):467-8. PubMed ID: 18573730
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases.
    Kong YY; Dai B; Kong JC; Lu HF; Shi DR
    Histopathology; 2009 Aug; 55(2):189-96. PubMed ID: 19694826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaplastic large-cell T-cell lymphoma.
    Stein JA; Soldano AC; Latkowski JA
    Dermatol Online J; 2008 May; 14(5):15. PubMed ID: 18627751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous CD30 positive anaplastic large cell lymphoma--report of a case treated with bexarotene.
    Oliveira A; Fernandes I; Alves R; Lima M; Selores M
    Leuk Res; 2011 Nov; 35(11):e190-2. PubMed ID: 21764128
    [No Abstract]   [Full Text] [Related]  

  • 14. Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma with interferon alfa and bexarotene therapy.
    French LE; Shapiro M; Junkins-Hopkins JM; Vittorio CC; Rook AH
    J Am Acad Dermatol; 2001 Dec; 45(6):914-8. PubMed ID: 11712039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous CD30+ anaplastic large-cell lymphomas mimicking keratoacanthomas.
    Martín JM; Ricart JM; Monteagudo C; Alcácer J; Pinazo I; Tomás L; Rausell N; Jordá E
    Clin Exp Dermatol; 2007 Nov; 32(6):668-71. PubMed ID: 17953637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare and isolated presentation of primary cutaneous anaplastic large cell lymphoma.
    Shah M; Pawar M; Zawar V
    Acta Dermatovenerol Alp Pannonica Adriat; 2018 Mar; 27(1):33-34. PubMed ID: 29589643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission of primary cutaneous anaplastic large cell lymphoma after a brief course of brentuximab vedotin.
    Desai A; Telang GH; Olszewski AJ
    Ann Hematol; 2013 Apr; 92(4):567-8. PubMed ID: 23086510
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary cutaneous anaplastic large cell lymphoma arising from a burn scar.
    Amoh Y; Tanabe K; Takasu H; Katsuoka K
    Eur J Dermatol; 2012; 22(3):420-1. PubMed ID: 22481116
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term bexarotene monotherapy in large cell CD30+ pleomorphic T-cell lymphoma.
    Aldaoud A
    Dermatol Clin; 2008 Jan; 26 Suppl 1():15-7. PubMed ID: 18405181
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose Methotrexate Treatment for Solitary or Localized Primary Cutaneous Anaplastic Large Cell Lymphoma: A Long-term Follow-up Study.
    Park JB; Yang MH; Kwon DI; Seong SH; Jang JY; Suh KS; Jang MS
    Acta Derm Venereol; 2020 Feb; 100(4):adv00069. PubMed ID: 31996929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.